It was another month of gains for the stock market, even as Wall Street had to navigate a barrage of uncertainty. Since the Investing Club’s last Monthly Meeting on Oct. 7, the S & P 500 jumped 2%. October marked the sixth month in a row of gains, despite the longest-ever government shutdown and valuation…
WASHINGTON — AstraZeneca is set to strike a deal with the Trump administration to lower drug prices, people familiar with the matter told STAT. More details are expected to be shared at a 5 p.m. announcement with President Trump in the Oval Office. It comes a day after the company said it would invest $4.5…
MUMBAI, INDIA – MARCH 3: A technician works at a Cipla laboratory March 3, 2002 in Vikhrohi, Mumbai, India. Jean-marc Giboux | 3rd Party – Misc | Getty Images Stocks of leading Indian drugmakers fell on Friday, even though the 100% U.S. tariffs on branded and patented drug imports are unlikely to affect these companies….
Rafael Henrique | Lightrocket | Getty Images Britain’s GSK on Wednesday became the latest pharmaceutical firm to commit bumper investment into the U.S., as President Donald Trump is in the U.K. for a three-day state visit. The drug maker committed to investing at least $30 billion in U.S. research and developing (R&D) and manufacturing over…
The U.K. is under pressure to offer a better deal to global pharmaceutical firms, as a slew of pulled investments and stalled drug pricing talks loom over U.S. President Donald Trump’s state visit to Britain. Drug companies have been urging U.K. authorities to pay more for drugs and improve the competitive landscape ahead of a…
U.S. Health and Human Services Secretary Robert F. Kennedy Jr., testifies before a Senate Finance Committee hearing on President Donald Trump’s 2026 health care agenda, on Capitol Hill in Washington, D.C., U.S., September 4, 2025. Jonathan Ernst | Reuters President Donald Trump on Tuesday signed a memorandum that aims to crack down on direct-to-consumer prescription…
Scott Bessent, US treasury secretary, in the Oval Office of the White House in Washington, DC, US, on Wednesday, Aug. 6, 2025. Bonnie Cash | Bloomberg | Getty Images Even if the U.S. Supreme Court agrees with a federal appeals court’s ruling that most of President Donald Trump’s tariffs are illegal, it doesn’t mean the…
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters New trial data suggests Novo Nordisk‘s weight loss drug Wegovy edges out rival treatments on heart condition risk reduction, in good news for the Danish pharma giant as it…
U.S. President Donald Trump in the Cabinet Room of the White House on Aug. 26, 2025 in Washington, D.C. Chip Somodevilla | Getty Images President Donald Trump on Monday called on pharmaceutical companies to “justify the success” of their Covid drugs days after the Food and Drug Administration set new limits on who can receive…
A pair of Hong Kong-listed mainland Chinese biotechnology firms are poised to turn a profit this year as their revenue from novel drugs finally outstrips costs related to research and development and marketing, according to analysts. “Chinese biotechs have matured significantly and are creating value for Chinese patients and government payers,” said Tony Ren, head…